Learn more on this topic: Collaborative Management of Patients with Advanced Estrogen Receptor-Positive Breast Cancer

At what point does a patient become a candidate for treatment with CDK inhibitors?

Lee S. Schwartzberg, MD, FACP
West Cancer Center

Copyright © 2010-2020 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.